Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01116
Species: Homo sapiens
Position : chr20:48900221-48901229
Year: 2019
Title: Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: hepatocellular carcinoma
PMID:  30659195
MONDO: MONDO:0007256
Tissue: liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Huh-7
CVCL ID: CVCL_0336
Experiment Type: Enhancer methylation mapping; endogenous enhancer deletion; enhancer-target and tumorigenic validation; Endogenous enhancer perturbation
High Throughput Method: MBDCap-seq; WGBS; ChIP-seq; RNA-seq; Hi-C; whole-genome sequencing
Low Throughput Method: CRISPR/Cas9 enhancer deletion; luciferase reporter assay; ChIP-qPCR; RT-qPCR; Western blot; bisulfite pyrosequencing; CRISPR-Cas9 endogenous deletion/editing
About Target Gene
Target gene : CEBPB
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 10 found
Enhancer ID Position Tissue Cell Disease
E_02876 chr20:48400000-49200000 breast malignant cell breast cancer
E_02877 chr20:48400000-49200000 breast malignant cell breast cancer
E_01098 chr20:48900221-48901229 liver hepatoblast hepatocellular carcinoma
E_01105 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01106 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01107 chr20:48900221-48901229 liver malignant cell hepatocellular carcinoma
E_01108 chr20:48900221-48901229 liver hepatocyte hepatocellular carcinoma
E_01115 chr20:48900221-48901229 liver NA hepatocellular carcinoma
E_01143 chr20:48900221-48901229 uterine cervix NA hepatocellular carcinoma
E_01145 chr20:48900221-48901229 liver NA hepatocellular carcinoma
Expression of Target Genes for the Enhancer